October 16, 2023 · STOCK Act disclosure
Representative Josh Gottheimer (Democrat-NJ) bought BioCryst Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on October 16, 2023 and was disclosed on November 11, 2023 (owner: JT). Members of Congress must report such transactions within 45 days under the STOCK Act.